Fighting Covid-19 with local innovations
More players in the biomedical sector are looking to expand their operations beyond R&D to small-to-medium-scale manufacturing.
AS the Covid-19 pandemic continues to rage around the globe, local small and medium-sized enterprises (SMEs) are meeting demand for diagnosis, treatment and protection solutions with homegrown innovations.
One of these companies, Gill Lab, took an unusual approach to balancing the demand and supply of surgical masks. Instead of setting up yet another mask manufacturing facility, it designed a reusable respirator that can extend the use of a surgical mask by up to six times. More than 100,000 units of the Gill Mask have already been sold worldwide since its launch in April.
Two others, Star Array and Lion TCR, are using capabilities in rapid testing technologies and virus treatments respectively to aid in testing and potentially treating the disease.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
SMEs
Sun rising for Singapore businesses breaking into Japan market
One in three Singapore SMEs expect AI to replace or take over jobs: survey
Fintech KPay aims to triple Singapore merchant base, double local workforce
Singapore SMEs in contractionary mode for fifth straight quarter: OCBC
B2K’s second-generation leaders paw a new path in pet products
Finding a growth vector with digital solutions